Eloxx Pharmaceuticals, Inc. (ELOX) NASDAQ
Currency In USD
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
AD
Currency In USD
| Market Cap | 112.25 |
| Enterprise Value | -3.79M |
| P/E Ratio | -10.51 |
| PEG Ratio | -0.12 |
| Price/Sales Ratio | 0 |
| Price/Book Ratio | 2.34 |
| Enterprise/Revenue | 0 |
| Enterprise/EBITDA | 0.87 |
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | June 30, 2026 |
| Profit Margin | 0 |
| Operating Margin | 0 |
| Return On Assets | -0.13 |
| Return On Equity | -0.43 |
| Revenue | 0 |
| Revenue/Share | 0 |
| Gross Profit | 0 |
| EBITDA | -4.95M |
| Net Income | -6M |
| Diluted EPS | -5.34 |
| Total Cash | 61.96M |
| Total Cash/Share | 9.13 |
| Total Debt | 0 |
| Total Debt/Equity | 0 |
| Current Ratio | 3.74 |
| Book Value Per Share | 6.84 |
| 52-Week Change | 15.97M |
| 52-Week High | 23.4 |
| 52-Week Low | 8.2 |
| Moving Average 50 Days | 15.22 |
| Moving Average 200 Days | 14.65 |
| Average Volume | 53,290 |
| Shares Outstanding | 3.44M |
| % Held by Institutions | 36.82 |
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | 1:11 |
| Last Split Date | June 01, 2026 |